|Articles|October 8, 2015
PPD Awarded U.S. Army and BARDA Research
Advertisement
PPD announced it has been awarded two separate United States government contracts. In one agreement, the U.S. Army selected PPD to provide health outcomes research for armed services personnel. For the Biomedical Advanced Research and Development Authority (BARDA), PPD will evaluate the potency and long-term stability of H5N1 influenza (avian influenza) vaccines from the Centers for Disease Control and Prevention’s Strategic National Stockpile.
Read
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
2
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
3
Unlocking Unstructured Health Data: Scaling eSource-Enabled Clinical Trials
4
ACT Brief: Rethinking Site Support in 2026, GSK’s New Severe Asthma Approval, and Priority Review Momentum in Multiple Myeloma
5